Known cooperation of mutant p53 with RAS family oncoproteins is more indirect—both pathways contribute to progression of neoplasia in parallel, e.g., in pancreatic cancer models [47,48]. This evidence concerns the gene TP53 and familial pancreatic carcinoma.